Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia restricts use of cough and cold medicines in children; new labelling required from 1 Sept

This article was originally published in SRA

Executive Summary

Drug sponsors marketing cough and cold medicines in Australia will have to start amending their labelling and packaging from 1 September onwards to state that such products should not be given to children below six years of age1. Labels will also have to reflect that for children aged six to 11 years, these medicines should only be allowed on the advice of a doctor, pharmacist or nurse practitioner.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS116929

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel